ePrior Authorization Real Benefits: Reducing Frictional Costs and Speeding Time to Therapy
Speaker: Ken Kleinberg, Practice Lead, Innovative Technologies, Point-of-Care Partners
Who should attend?: Payers, Providers, Life Sciences companies and the stakeholders who support them.
Join us on May 30th for our webinar focused on delivering the high-level findings of our most recent industry report “ePrior Authorization’s Real Benefits: Reducing Frictional Costs and Speeding Time to Therapy.”
Automating the prior authorization process through ePrior Authorization (ePA) will be key to reducing costs, speeding time to therapy and improving patient care, however, there are many complex areas where significant progress is yet to be made, such as with specialty meds, and for procedures, devices, and services. Point-of-Care Partners gathered our ePA experts and set out to analyze the current state of ePA, imagine its best-case future, and advise organization on the road forward. Our 107-page industry report entitled “ePrior Authorization’s Real Benefits: Reducing Frictional Costs and Speeding Time to Therapy” has 40+ diagrams & tables, 40+ vendor profiles, 90+ references, and actionable advice for stakeholders to take. Ken Kleinberg will discuss why multi-stakeholder coordination is imperative for successful ePA as well as highlight:
- Current market conditions and drivers for ePA
- Required ePA technical components
- ePA maturity model
- Future ePA outlook